home / stock / tlsa / tlsa quote
Last: | $0.454 |
---|---|
Change Percent: | 0.0% |
Open: | $0.42 |
Close: | $0.454 |
High: | $0.46 |
Low: | $0.4182 |
Volume: | 33,105 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.454 | $0.42 | $0.454 | $0.46 | $0.4182 | 33,105 | 03-29-2024 |
$0.454 | $0.42 | $0.454 | $0.46 | $0.4182 | 33,105 | 03-28-2024 |
$0.417 | $0.435 | $0.417 | $0.457 | $0.417 | 64,900 | 03-27-2024 |
$0.426 | $0.45 | $0.426 | $0.472501 | $0.412 | 73,939 | 03-26-2024 |
$0.453 | $0.4701 | $0.453 | $0.4936 | $0.445 | 79,854 | 03-25-2024 |
$0.465 | $0.47 | $0.465 | $0.48 | $0.464 | 19,443 | 03-22-2024 |
$0.464 | $0.48 | $0.464 | $0.492 | $0.464 | 44,974 | 03-21-2024 |
$0.48 | $0.472801 | $0.48 | $0.496 | $0.472801 | 15,852 | 03-20-2024 |
$0.49 | $0.502201 | $0.49 | $0.5197 | $0.471 | 27,607 | 03-19-2024 |
$0.5153 | $0.475 | $0.5153 | $0.5378 | $0.4537 | 116,659 | 03-18-2024 |
$0.4997 | $0.5 | $0.4997 | $0.5075 | $0.485 | 27,660 | 03-15-2024 |
$0.5076 | $0.495 | $0.5076 | $0.51 | $0.49 | 64,093 | 03-14-2024 |
$0.5024 | $0.504951 | $0.5024 | $0.5099 | $0.465 | 54,407 | 03-13-2024 |
$0.49 | $0.5 | $0.49 | $0.51 | $0.4798 | 39,722 | 03-12-2024 |
$0.499 | $0.497 | $0.499 | $0.51 | $0.474 | 57,744 | 03-11-2024 |
$0.487 | $0.486 | $0.487 | $0.519399 | $0.475 | 80,805 | 03-08-2024 |
$0.5187 | $0.5 | $0.5187 | $0.54 | $0.4855 | 120,492 | 03-07-2024 |
$0.4801 | $0.525 | $0.4801 | $0.53 | $0.471 | 163,741 | 03-06-2024 |
$0.515 | $0.4584 | $0.515 | $0.515 | $0.452 | 1,047,940 | 03-05-2024 |
$0.4699 | $0.46 | $0.4699 | $0.4848 | $0.45 | 148,535 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Data shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer's disease (AD) and Parkinson's d...
Data shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer’s disease (AD) and Parkinson’s disease (PD) Nasal anti-CD3 reduced hemorrhage and edema that occurs with ARIA based on animal studies Neuroinflammation modulation m...
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced positive findings have been seen in a total o...